Limitations in the Use of Serum Epidermal Growth Factor Receptor Mutations as Prognostic Markers for Non-Small-Cell Lung Cancer

OBJECTIVES: In this study, we surveyed patients with advanced non-small-cell lung cancer (NSCLC) who were undergoing tyrosine kinase inhibitor (TKI)-targeted therapy. Our aim was to determine whether epidermal growth factor receptor (EGFR) mutations in serum circulating tumor (ct)DNA are useful prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yongjun, Bao, Wenlong, Li, Zhijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588260/
https://www.ncbi.nlm.nih.gov/pubmed/26068378
http://dx.doi.org/10.1159/000431326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588260/
https://www.ncbi.nlm.nih.gov/pubmed/26068378
http://dx.doi.org/10.1159/000431326

Ejemplares similares